Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1990-3-7
|
| pubmed:abstractText |
Efficacy and safety of oral ciprofloxacin (500-1000 mg/die) were evaluated in 231 patients with bacteriologically documented infections of the urinary tract. The clinical resolution rate was 89.6% with eradication of the aetiological organism in 90.1% of cases. Superinfection, both bacterial or fungal, as well as side-effects were minimal. It is concluded that ciprofloxacin represents an effective and safe therapy in urinary tract infections.
|
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0393-2249
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
41
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
201-5
|
| pubmed:dateRevised |
2008-6-23
|
| pubmed:meshHeading |
pubmed-meshheading:2694397-Administration, Oral,
pubmed-meshheading:2694397-Adult,
pubmed-meshheading:2694397-Bacterial Infections,
pubmed-meshheading:2694397-Ciprofloxacin,
pubmed-meshheading:2694397-Female,
pubmed-meshheading:2694397-Humans,
pubmed-meshheading:2694397-Male,
pubmed-meshheading:2694397-Multicenter Studies as Topic,
pubmed-meshheading:2694397-Urinary Tract Infections
|
| pubmed:articleTitle |
[Ciprofloxacin in urinary infections: analysis of the Italian data pool].
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Multicenter Study
|